FourThought Financial’s Acadia Pharmaceuticals ACAD Stock Holding History

FourThought Financial’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-106	Closed	-$2K	–	1534
2021 Q1	$2K	Sell	106 -2,653	-96%	-$117K	﹤0.01%	1286
2020 Q4	$147K	Buy	+2,759	New	+$137K	0.02%	396

Other funds holding ACAD

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

FourThought Financial's ACAD Position: Q2 2021 in Review

FourThought Financial sold out of Acadia Pharmaceuticals (ACAD) in Q2 2021, closing a stake of 106 shares — an estimated $2K sold.

FourThought Financial first reported a position in ACAD in Q4 2020 and held it in 2 quarters. The position peaked at $147K in Q4 2020. 245 funds tracked by Wall St. Rank hold ACAD as of Q2 2021.

FourThought Financial reported no remaining Acadia Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
FourThought Financial sold 106 Acadia Pharmaceuticals shares in Q2 2021, an estimated $2K.
FourThought Financial first reported a position in Acadia Pharmaceuticals in Q4 2020 and held it in 2 quarters.
FourThought Financial's Acadia Pharmaceuticals position peaked at $147K in Q4 2020.
245 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2021.

Based on FourThought Financial's 13F filing for Q2 2021, filed 12 Nov 2021.